Evidence map›Paper›PMID 39072895›Full record

ArticleJournal of applied clinical medical physics2024

Adaptive assessment based on fractional CBCT images for cervical cancer.

Yankui Chang, Yongguang Liang, Haotian Wu, Lingyan Li, Bo Yang, Lipeng Jiang, Qiang Ren, Xi Pei

Abstract read
In one paragraph

Article in Journal of applied clinical medical physics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Adaptive assessment based on fractional CBCT images for cervical cancer.Journal of applied clinical medical physics · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yankui ChangSchool of Nuclear Science and Technology, University of Science and Technology of China, Hefei, China.ORCID https://orcid.org/0000-0001-9814-0332
Yongguang LiangDepartment of Radiation Oncology, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Beijing, China.
Haotian WuAnhui Wisdom Technology Company Limited, Hefei, China.
Lingyan LiAnhui Wisdom Technology Company Limited, Hefei, China.
Bo YangDepartment of Radiation Oncology, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Beijing, China.
Lipeng JiangDepartment of Radiation Oncology, First Affiliated Hospital of Jinzhou Medical University, Shenyang, China.
Qiang RenAnhui Wisdom Technology Company Limited, Hefei, China.
Xi PeiSchool of Nuclear Science and Technology, University of Science and Technology of China, Hefei, China.

Funding

14th Five-year Plan 2023YFC2411500National Natural Science Foundation of China 12275372USTC Fund for New Medicine-Innovation Team Project YD2140002002USTC Fund for the Development of Medical Physics and Biomedical Engineering Interdisciplinary Subjects YD2140000601
6 · The paper itself

Abstract

purposeAnatomical and other changes during radiotherapy will cause inaccuracy of dose distributions, therefore the expectation for online adaptive radiation therapy (ART) is high in effectively reducing uncertainties due to intra-variation. However, ART requires extensive time and effort. This study investigated an adaptive assessment workflow based on fractional cone-beam computed tomography (CBCT) images.

methodsImage registration, synthetic CT (sCT) generation, auto-segmentation, and dose calculation were implemented and integrated into ArcherQA Adaptive Check. The rigid registration was based on ITK open source. The deformable image registration (DIR) method was based on a 3D multistage registration network, and the sCT generation method was performed based on a 2D cycle-consistent adversarial network (CycleGAN). The auto-segmentation of organs at risk (OARs) on sCT images was finished by a deep learning-based auto-segmentation software, DeepViewer. The contours of targets were obtained by the structure-guided registration. Finally, the dose calculation was based on a GPU-based Monte Carlo (MC) dose code, ArcherQA.

resultsThe dice similarity coefficient (DSCs) were over 0.86 for target volumes and over 0.79 for OARs. The gamma pass rate of ArcherQA versus Eclipse treatment planning system was more than 99% at the 2%/2 mm criterion with a low-dose threshold of 10%. The time for the whole process was less than 3 min. The dosimetric results of ArcherQA Adaptive Check were consistent with the Ethos scheduled plan, which can effectively identify the fractions that need the implementation of the Ethos adaptive plan.

conclusionThis study integrated AI-based technologies and GPU-based MC technology to evaluate the dose distributions using fractional CBCT images, demonstrating remarkably high efficiency and precision to support future ART processes.

Indexed as

Cone-Beam Computed TomographyImage Processing, Computer-AssistedOrgans at RiskRadiotherapy DosageRadiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-AssistedUterine Cervical NeoplasmsAlgorithmsFemaleHumansMonte Carlo MethodSoftwareadaptive assessmentadaptive radiotherapyartificial intelligencefractional CBCT imagesMonte Carlo based dose calculation

Identifiers

PMID39072895
PMCPMC11466466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.